An overview of the patterns of prescription opioid use, costs and related harms in Australia

British Journal of Clinical Pharmacology

Volumn 78, Issue 5, 2014, Pages 1159-1166

  Blanch, Bianca ^a   Pearson, Sallie Anne ^a,b   Haber, Paul S ^b,c  

^a UNIVERSITY OF SYDNEY   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

^c ROYAL PRINCE ALFRED HOSPITAL   (Australia)

Author keywords

Australia; death; drug utilization; factual databases; hospitalization; opioid analgesics

Indexed keywords

ALFENTANIL; BUPRENORPHINE; CODEINE; DEXTROPROPOXYPHENE; DIAMORPHINE; FENTANYL; HYDROMORPHONE; METHADONE; MORPHINE; OPIATE; OXYCODONE; PETHIDINE; TAPENTADOL; TRAMADOL; NARCOTIC ANALGESIC AGENT; PRESCRIPTION DRUG;

ACCIDENTAL DEATH; AUSTRALIA; AUSTRALIAN; CONFERENCE PAPER; DRUG COST; DRUG INTOXICATION; DRUG USE; GOVERNMENT; HOSPITALIZATION; HUMAN; MORTALITY; PRESCRIPTION; PRIORITY JOURNAL; DRUG OVERDOSE; DRUG UTILIZATION; ECONOMICS; EPIDEMIOLOGY; INAPPROPRIATE PRESCRIBING; STATISTICS AND NUMERICAL DATA; TRENDS;

ANALGESICS, OPIOID; AUSTRALIA; DRUG COSTS; DRUG OVERDOSE; DRUG UTILIZATION; HOSPITALIZATION; HUMANS; INAPPROPRIATE PRESCRIBING; PRESCRIPTION DRUGS;

EID: 84919326181     PISSN: 03065251     EISSN: 13652125     Source Type: Journal    
DOI: 10.1111/bcp.12446     Document Type: Conference Paper

References (46)

1. Ballantyne JC,. Chronic opioid therapy and its utility in different populations. Pain 2012; 153: 2303-2304.
2. Kissin I,. Long-term opioid treatment of chronic nonmalignant pain: unproven efficacy and neglected safety? J Pain Res 2013; 6: 513-529.
3. Kuehn BM,. Opioid prescriptions soar: increase in legitimate use as well as abuse. JAMA 2007; 297: 249-251.
4. Manchikanti L, Fellows B, Ailinani H, Pampati V,. Therapeutic use, abuse, and nonmedical use of opioids: a ten-year perspective. Pain Physician 2010; 13: 401-435.
5. Manchikanti L, Helm S 2nd, Fellows B, Janata JW, Pampati V, Grider JS, Boswell MV,. Opioid epidemic in the United States. Pain Physician 2012; 15: ES9-38.
6. Manchikanti L, Singh A,. Therapeutic opioids: a ten-year perspective on the complexities and complications of the escalating use, abuse, and nonmedical use of opioids. Pain Physician 2008; 11: S63-88.
7. Casati A, Sedefov R, Pfeiffer-Gerschel T,. Misuse of medicines in the European Union: a systematic review of the literature. Eur Addict Res 2012; 18: 228-245.
8. The Royal Australian & New Zealand College of Psychiatrists. Response to the national pharmaceutical drug misuse strategy. 2011. Available at https://www.ranzcp.org/Files/Resources/Submissions/sub61-pdf.aspx (last accessed 1 December 2013).
9. Nicholas R, Lee N, Roche A,. Pharmaceutical Drug Misuse in Australia: Complex Problems, Balanced Responses. National Centre for Education and Training on Addiction (NCETA) (ed). Adelaide: Flinders University, 2011.
10. Zacny J, Bigelow G, Compton P, Foley K, Iguchi M, Sannerud C,. College on Problems of Drug Dependence taskforce on prescription opioid non-medical use and abuse: position statement. Drug Alcohol Depend 2003; 69: 215-232.
11. Leong M, Murnion B, Haber PS,. Examination of opioid prescribing in Australia from 1992 to 2007. Intern Med J 2009; 39: 676-681.
12. Berbatis CG, Sunderland VB, Bulsara M, Lintzeris N,. Trends in licit opioid use in Australia, 1984-1998: comparative analysis of international and jurisdictional data. Med J Aust 2000; 173: 524-527.
13. Degenhardt L, Black E, Breen C, Bruno R, Kinner S, Roxburgh A, Fry C, Jenkinson R, Ward J, Fetherston J, Weekley J, Fischer J,. Trends in morphine prescriptions, illicit morphine use and associated harms among regular injecting drug users in Australia. Drug Alcohol Rev 2006; 25: 403-412.
14. Roxburgh A, Burns L, Drummer OH, Pilgrim J, Farrell M, Degenhardt L,. Trends in fentanyl prescriptions and fentanyl-related mortality in Australia. Drug Alcohol Rev 2013; 32: 269-275.
15. Roxburgh A, Bruno R, Larance B, Burns L,. Prescription of opioid analgesics and related harms in Australia. Med J Aust 2011; 195: 280-284.
16. Bell JR,. Australian trends in opioid prescribing for chronic non-cancer pain, 1986-1996. Med J Aust 1997; 167: 26-29.
17. Hollingworth SA, Symons M, Khatun M, Loveday B, Ballantyne S, Hall WD, Najman JM,. Prescribing databases can be used to monitor trends in opioid analgesic prescribing in Australia. Aust N Z J Public Health 2013; 37: 132-138.
18. Rintoul AC, Dobbin MDH, Drummer OH, Ozanne-Smith J,. Increasing deaths involving oxycodone, Victoria, Australia, 2000-09. Inj Prev 2011; 17: 254-259.
19. World Health Organisation. The ICD-10 Classification of Mental and Behavioural Disorders-Diagnostic Criteria for Research. Geneva: WHO, 1993.
20. Australian Institute of Health and Welfare. Separation statistics by principal diagnosis in ICD-10-AM, 1998-99 to 2007-08. 2013. Available at http://www.aihw.gov.au/hospitals-data/principal-diagnosis-data-cubes/ (last accessed 1 October 2013).
21. Australian Institute of Health and Welfare. Separation statistics by principal diagnosis in ICD-10-AM, 2008-09 to 2009-10. http://www.aihw.gov.au/hospitals-data/principal-diagnosis-data-cubes/ (last accessed 1 October 2013).
22. Henderson T, Shepheard J, Sundararajan V,. Quality of diagnosis and procedure coding in ICD-10 administrative data. Med Care 2006; 44: 1011-1019.
23. Australian Bureau of Statistics. Causes of death, Australia, 2011. Available at http://www.abs.gov.au/AUSSTATS/absnsf/DetailsPage/3303.02011?OpenDocument (last accessed 4 October 2013).
24. Australian Government Department of Health. PBAC outcomes. Available at http://www.pbs.gov.au/info/industry/listing/elements/pbac-meetings/pbac-outcomes (last accessed 10 October 2013).
25. Gadzhanova S, Bell JS, Roughead EE,. What analgesics do older people use prior to initiating oxycodone for non-cancer pain? A retrospective database study. Drugs Aging 2013; 30: 921-926.
26. Poulsen KK, Andersen SE, Moreno SI, Glintborg D, Thirstrup S, Aagaard L,. General practitioners' and hospital physicians' preference for morphine or oxycodone as first-time choice for a strong opioid: a national register-based Study. Basic Clin Pharmacol Toxicol 2013; 112: 110-115.
27. Garcia del Pozo J, Carvajal A, Viloria JM, Velasco A, Garcia del Pozo V,. Trends in the consumption of opioid analgesics in Spain. Higher increases as fentanyl replaces morphine. Eur J Clin Pharmacol 2008; 64: 411-415.
28. Maher RL, Hanlon J, Hajjar ER,. Clinical consequences of polypharmacy in elderly. Expert Opin Drug Saf 2014; 13: 57-65.
29. Australian Bureau of Statistics. Characteristics of bodily pain in Australia. 2012. Available at http://www.abs.gov.au/ausstats/absnsf/Lookup/4841.0Chapter12011 (last accessed 14 November 2013).
30. Fairchild A,. Under-treatment of cancer pain. Curr Opin Support Palliat Care 2010; 4: 11-15.
31. Longo MC, Henry-Edwards SM, Humeniuk RE, Christie P, Ali RL,. Impact of the heroin 'drought' on patterns of drug use and drug-related harms. Drug Alcohol Rev 2004; 23: 143-150.
32. Fredheim OM, Skurtveit S, Breivik H, Borchgrevink PC,. Increasing use of opioids from 2004 to 2007-pharmacoepidemiological data from a complete national prescription database in Norway. Eur J Pain 2010; 14: 289-294.
33. Hudec R, Tisonova J, Bozekova L, Foltan V,. Trends in consumption of opioid analgesics in Slovak Republic during 1998-2002. Eur J Clin Pharmacol 2004; 60: 445-448.
34. Schumann H, Erickson T, Thompson TM, Zautcke JL, Denton JS,. Fentanyl epidemic in Chicago, Illinois and surrounding Cook County. Clin Toxicol 2008; 46: 501-506.
35. Porucznik CA, Johnson EM, Sauer B, Crook J, Rolfs RT,. Studying adverse events related to prescription opioids: the Utah experience. Pain Med 2011; 12: (Suppl 2): S16-25.
36. Stannard C,. Opioids in the UK: what's the problem? BMJ 2013; 347: f5108.
37. Unick GJ, Rosenblum D, Mars S, Ciccarone D,. Intertwined epidemics: national demographic trends in hospitalizations for heroin- and opioid-related overdoses, 1993-2009. PLoS ONE 2013; 8: e54496.
38. Coben JH, Davis SM, Furbee PM, Sikora RD, Tillotson RD, Bossarte RM,. Hospitalizations for poisoning by prescription opioids, sedatives, and tranquilizers.[Erratum appears in Am J Prev Med. 2010 Dec;39(6):613]. Am J Prev Med 2010; 38: 517-524.
39. Lloyd BK, McElwee PR,. Trends over time in characteristics of pharmaceutical drug-related ambulance attendances in Melbourne. Drug Alcohol Rev 2011; 30: 271-280.
40. Hall AJ, Logan JE, Toblin RL, Kaplan JA, Kraner JC, Bixler D, Crosby AE, Paulozzi LJ,. Patterns of abuse among unintentional pharmaceutical overdose fatalities. JAMA 2008; 300: 2613-2620.
41. Jones CM, Mack KA, Paulozzi LJ,. Pharmaceutical overdose deaths, United States, 2010. JAMA 2013; 309: 657-659.
42. Paulozzi LJ, Kilbourne EM, Shah NG, Nolte KB, Desai HA, Landen MG, Harvey W, Loring LD,. A history of being prescribed controlled substances and risk of drug overdose death. Pain Med 2012; 13: 87-95.
43. Paulozzi LJ, Logan JE, Hall AJ, McKinstry E, Kaplan JA, Crosby AE,. A comparison of drug overdose deaths involving methadone and other opioid analgesics in West Virginia. Addiction 2009; 104: 1541-1548.
44. Darnall BD, Stacey BR, Chou R,. Medical and psychological risks and consequences of long-term opioid therapy in women. Pain Med 2012; 13: 1181-1211.
45. Centers for Disease Control and Prevention. Vital signs: prescription painkiller overdoses: a growing epidemic, especially among women. 2013. Available at http://www.cdc.gov/vitalsigns/PrescriptionPainkillerOverdoses/index.html (last accessed 1 October 2013).
46. The National Centre for Education and Training on Addiction. National pharmaceutical drug misuse strategy. Available at http://nceta.flinders.edu.au/society/projects-and-research/national-pharmaceutical-drug-misuse-strategy/ (last accessed 1 December 2013).